"Phase III double-blinded, placebo-controlled study of MABp1 for improving survival in metastatic colorectal cancer." by Sanjay Goel

Selected Works of Antonio Ucar

Follow Contact

Presentation

Phase III double-blinded, placebo-controlled study of MABp1 for improving survival in metastatic colorectal cancer.

2016 Gastrointestinal Cancers Symposium (2016)

Sanjay Goel, Montefiore Medical Center
Lucjan Wyrwicz
Minsig Choi, Wayne State University
Andrew L. Coveler, University of Washington
Antonio Ucar
Alexander Ward Brown
Tomasz Sarosiek
Lucas Wong, Scott & White Hospital
Michael Stecher
George A. Fisher, Stanford University
Andrew Eugene Hendifar, Cedars-Sinai Medical Center

Link

Disciplines

Medicine and Health Sciences,
Pathology and
Immunology and Infectious Disease

Publication Date

January, 2016

Location

San Francisco, CA

DOI

10.1200/jco.2016.34.4_suppl.tps784

Citation Information

Sanjay Goel, Lucjan Wyrwicz, Minsig Choi, Andrew L. Coveler, et al.. "Phase III double-blinded, placebo-controlled study of MABp1 for improving survival in metastatic colorectal cancer." 2016 Gastrointestinal Cancers Symposium (2016)
Available at: http://works.bepress.com/antonio-ucar/4/